Brief: Shineco Subsidiary Granted USPTO Patent And FDA Marketing Approval For Its In-situ Fecal Specimen Sampling Device
07/12/2022 14:14
Dec 7 (Reuters) - Shineco Inc SISI.O :
* SHINECO, INC SUBSIDIARY, GRANTED USPTO PATENT AND FDA
MARKETING
APPROVAL FOR ITS IN-SITU FECAL SPECIMEN SAMPLING DEVICE
Source text for Eikon: ID:nGNX2wggkx
Further company coverage: SISI.O
Recent news on Shineco
See all newsBrief: Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform Strategic Acquisition Expands Global Blockchain-Biotech Network
Brief: Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
Brief: Shineco Inc To Effect 50:1 Reverse Stock Split
Brief: Shineco Inc - To Sell 18 Million Shares At $0.75 Each
Brief: Shineco Announces Acquisition Of Singapore Evolutionary Stem Cell Company